This is a preview of subscription content, access via your institution
Access options
References
Rubner, J. Nature 382, 104 (1996).
Blaschke, G., Kraft, H. P., Fickentscher, K. & Köhler, F. Drug Res. 29, 1640–1642 (1979).
Scott, W. J., Fradkin, R. & Wilson, J. G. Teratology 16, 333–336 (1977).
Fabro, S., Smith, R. L. & Williams, R. T. Nature 2l5, 296 (1967).
Eriksson, T., Björkman, S., Roth, B., Fyge, A. & H¨glund, P. Chirality 7, 44–52 (1995).
Zwingenberger, K. & Wnendt, S. J. Inflammation 46, 177–211 (1996).
Wnendt, S. et al. Chirality 8, 390–396 (1996).
Büch, H. P., Omlor, G. & Knabe, J. Drug Res. 40, 32–36 (1990).
Heger, W. et al. Teratog. Carcinog. Mutagen. 14, 115–122 (1994).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Wnendt, S., Zwingenberger, K. Thalidomide's chirality. Nature 385, 303–304 (1997). https://doi.org/10.1038/385303b0
Issue Date:
DOI: https://doi.org/10.1038/385303b0
This article is cited by
-
3D-chiral (2.5) atom-based TOMOCOMD-CARDD descriptors: theory and QSAR applications to central chirality codification
Journal of Mathematical Chemistry (2008)
-
Ab initio calculation of molecular chiroptical properties
Theoretical Chemistry Accounts (2006)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.